USC Norris Comprehensive Cancer Center

USC Norris Comprehensive Cancer Center
Name	USC Norris Comprehensive Cancer Center
Established	1973
Type	Academic cancer center
Parent	University of Southern California
Location	Los Angeles, California

USC Norris Comprehensive Cancer Center is a research and clinical oncology center affiliated with the University of Southern California and located in Los Angeles, California. The center operates as a hub for translational oncology that connects laboratory investigators, clinical practitioners, and community outreach programs across Southern California. It collaborates with major institutions, hospitals, and funding agencies to advance cancer prevention, diagnosis, and treatment.

History

Founded in 1973, the center emerged during a period when the National Cancer Act of 1971 accelerated federal support for cancer research and prompted institutions such as the National Cancer Institute to designate comprehensive centers. Early leadership drew investigators with ties to institutions like the MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, and Fred Hutchinson Cancer Center. Over ensuing decades the center expanded partnerships with hospitals including Keck Hospital of USC, Children's Hospital Los Angeles, and regional networks such as Cedars-Sinai Medical Center. Major milestones included designation changes, programmatic expansion influenced by collaborations with the American Cancer Society and receipt of competitive awards from agencies such as the National Institutes of Health and private philanthropies like the W. M. Keck Foundation.

Facilities and Research Programs

Research infrastructure spans basic science laboratories, translational suites, and clinical trial units integrated with USC campus resources and affiliated sites like LAC+USC Medical Center. Core facilities include genomics and proteomics platforms that interface with consortia such as the Human Genome Project legacy resources and the Cancer Genome Atlas. Research programs cover translational oncology themes linked to investigators who previously trained at centers such as Johns Hopkins Hospital, Dana-Farber Cancer Institute, and Sloan Kettering Institute. Multidisciplinary centers focus on areas long emphasized in regional practice patterns: head and neck oncology tied to faculty from H. Lee Moffitt Cancer Center, neuro-oncology with links to researchers from UCLA Medical Center, and immuno-oncology teams collaborating with groups at Stanford Health Care and University of California, San Francisco. Biostatistics and bioinformatics cores interact with networks such as the Clinical and Translational Science Awards consortium.

Clinical Services and Patient Care

Clinical programs provide multidisciplinary care in medical oncology, surgical oncology, radiation oncology, and subspecialty clinics mirroring standards from institutions like Massachusetts General Hospital, Cleveland Clinic, and Mount Sinai Hospital. The center runs phase I–III clinical trials in partnership with cooperative groups such as the Children's Oncology Group, Alliance for Clinical Trials in Oncology, and industry sponsors including multinational pharmaceutical companies. Patient navigation and survivorship services coordinate with community partners like the American Society of Clinical Oncology outreach initiatives and local advocacy groups including the Susan G. Komen affiliates. Palliative care and symptom management teams align with practices from leading hospices and tertiary centers, and integration with regional electronic medical record systems supports tumor boards and multidisciplinary case conferences.

Education and Training

Educational programs train medical oncologists, surgical fellows, radiation oncology residents, and research scientists through affiliations with the Keck School of Medicine of USC and postgraduate pathways comparable to those at Johns Hopkins University School of Medicine and Harvard Medical School. Graduate students and postdoctoral fellows engage in translational projects linked to NIH training grants, the Cancer Biology Training Grant model, and collaborations with professional societies such as the American Association for Cancer Research and the American Society for Radiation Oncology. Continuing medical education offerings attract clinicians from networks spanning California Medical Association constituencies and national specialty societies.

Notable Research and Achievements

Investigators at the center have contributed to advances in targeted therapy, immunotherapy, and molecular diagnostics, publishing findings alongside collaborators from Broad Institute, Salk Institute for Biological Studies, and Cold Spring Harbor Laboratory. Achievements include participation in landmark genomic profiling efforts influenced by the Cancer Genome Atlas and contributions to checkpoint inhibitor research that parallel work at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute. The center has led community-based screening and prevention trials modeled on programs from the American Cancer Society and has received recognition from regional foundations and award-giving bodies tied to oncology breakthroughs.

Governance and Funding

Governance structures align with the administrative framework of the University of Southern California and involve leadership drawn from academic departments comparable to those at Columbia University Irving Medical Center and Yale School of Medicine. Funding combines federal grants from agencies such as the National Institutes of Health and the National Cancer Institute, philanthropy from donors with patterns similar to gifts from the Robert Wood Johnson Foundation and private foundations, and clinical revenue from partnerships with hospital systems like Keck Hospital of USC and regional insurers. Advisory boards include clinicians, scientists, and community representatives reflecting models used by other designated centers and cooperative groups.

Category:Oncology research centers in the United States Category:Medical research institutes in California